Shopping Cart 0
Cart Subtotal
USD 0

French National Institute of Health and Medical Research - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

French National Institute of Health and Medical Research (INSERM) is a biomedical research institute that conducts research in biology, medicine and public health. The institute offers research in the therapeutic areas of neurosciences, cognitive sciences, neurology, psychiatry, cancer, immunology, inflammation, genetics, cancer, infectiology and microbiology, physiopathology, public health, health technologies, metabolism, cell biology and immunology, among others. It provides services in the areas of human diseases and research findings to the medical community, and to both national and international partners. INSERM also conducts translational research and development services. It operates research units and research centers. INSERM is headquartered in Paris, France.

French National Institute of Health and Medical Research-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

French National Institute of Health and Medical Research, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

French National Institute of Health and Medical Research, Medical Equipment Deals By Type, 2012 to YTD 2018 6

French National Institute of Health and Medical Research, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

French National Institute of Health and Medical Research, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

French National Institute of Health and Medical Research, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

French National Institute of Health and Medical Research, Medical Equipment, Deal Details 11

Venture Financing 11

Eyevensys Secures Venture Funding 11

BioAxial Raises USD 2.6 Million In Series A Financing 12

Partnerships 13

Advanced Biological Labs Enters into Licensing Agreement with Inserm Transfert 13

Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 14

Tataa Biocenter Enters into Licensing Agreement with Inserm for ValidPrime Technology 15

IntegraGen Enters Into Licensing Agreement With Paris Descartes University For hsa-miR-31-3p 16

Qiagen Enters Into Licensing Agreement With Inserm Transfert For Colorectal Cancer Biomarker 18

Dassault Systemes Enters into Agreement with Inserm Transfert 19

Sebia Enters Into Co-Development Agreement With Institut National de la Sante And Inserm Transfert 20

Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 21

Inserm Transfert Enters into Licensing Agreement with HalioDx 22

PEP-Therapy Enters into Agreement with Inserm Transfert, Institut Curie and Pierre and Marie 23

French National Institute of Health and Medical Research-Key Competitors 24

French National Institute of Health and Medical Research-Key Employees 25

French National Institute of Health and Medical Research-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Affiliate 26

Recent Developments 27

Government and Public Interest 27

Jun 01, 2018: Immunoscore: a test to improve the care and treatment of colon cancer 27

Product News 28

Aug 31, 2018: Implantable electronic device could stop epileptic seizures 28

Other Significant Developments 29

Aug 20, 2018: Bioengineered tooth replacement opens doors to new therapies 29

Appendix 30

Methodology 30

About GlobalData 30

Contact Us 30

Disclaimer 30


List Of Figure

List of Figures

French National Institute of Health and Medical Research, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

French National Institute of Health and Medical Research, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

French National Institute of Health and Medical Research, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

French National Institute of Health and Medical Research, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

French National Institute of Health and Medical Research, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

French National Institute of Health and Medical Research, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

French National Institute of Health and Medical Research, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

French National Institute of Health and Medical Research, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

French National Institute of Health and Medical Research, Medical Equipment, Key Facts 2

French National Institute of Health and Medical Research, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

French National Institute of Health and Medical Research, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

French National Institute of Health and Medical Research, Medical Equipment Deals By Type, 2012 to YTD 2018 6

French National Institute of Health and Medical Research, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

French National Institute of Health and Medical Research, Deals By Market, 2012 to YTD 2018 8

French National Institute of Health and Medical Research, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Eyevensys Secures Venture Funding 11

BioAxial Raises USD 2.6 Million In Series A Financing 12

Advanced Biological Labs Enters into Licensing Agreement with Inserm Transfert 13

Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 14

Tataa Biocenter Enters into Licensing Agreement with Inserm for ValidPrime Technology 15

IntegraGen Enters Into Licensing Agreement With Paris Descartes University For hsa-miR-31-3p 16

Qiagen Enters Into Licensing Agreement With Inserm Transfert For Colorectal Cancer Biomarker 18

Dassault Systemes Enters into Agreement with Inserm Transfert 19

Sebia Enters Into Co-Development Agreement With Institut National de la Sante And Inserm Transfert 20

Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 21

Inserm Transfert Enters into Licensing Agreement with HalioDx 22

PEP-Therapy Enters into Agreement with Inserm Transfert, Institut Curie and Pierre and Marie 23

French National Institute of Health and Medical Research, Key Competitors 24

French National Institute of Health and Medical Research, Key Employees 25

French National Institute of Health and Medical Research, Subsidiaries 26

French National Institute of Health and Medical Research, Affiliate 26

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

French National Institute of Health and Medical Research, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

French National Institute of Health and Medical Research (INSERM) is a biomedical research institute that conducts research in biology, medicine and public health. The institute offers research in the therapeutic areas of neurosciences, cognitive sciences, neurology, psychiatry, cancer, immunology, inflammation, genetics, cancer, infectiology and microbiology, physiopathology, public health, health technologies, metabolism, cell biology and immunology, among others. It provides services in the areas of human diseases and research findings to the medical community, and to both national and international partners. INSERM also conducts translational research and development services. It operates research units and research centers. INSERM is headquartered in Paris, France.

French National Institute of Health and Medical Research-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

French National Institute of Health and Medical Research, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

French National Institute of Health and Medical Research, Medical Equipment Deals By Type, 2012 to YTD 2018 6

French National Institute of Health and Medical Research, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

French National Institute of Health and Medical Research, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

French National Institute of Health and Medical Research, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

French National Institute of Health and Medical Research, Medical Equipment, Deal Details 11

Venture Financing 11

Eyevensys Secures Venture Funding 11

BioAxial Raises USD 2.6 Million In Series A Financing 12

Partnerships 13

Advanced Biological Labs Enters into Licensing Agreement with Inserm Transfert 13

Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 14

Tataa Biocenter Enters into Licensing Agreement with Inserm for ValidPrime Technology 15

IntegraGen Enters Into Licensing Agreement With Paris Descartes University For hsa-miR-31-3p 16

Qiagen Enters Into Licensing Agreement With Inserm Transfert For Colorectal Cancer Biomarker 18

Dassault Systemes Enters into Agreement with Inserm Transfert 19

Sebia Enters Into Co-Development Agreement With Institut National de la Sante And Inserm Transfert 20

Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 21

Inserm Transfert Enters into Licensing Agreement with HalioDx 22

PEP-Therapy Enters into Agreement with Inserm Transfert, Institut Curie and Pierre and Marie 23

French National Institute of Health and Medical Research-Key Competitors 24

French National Institute of Health and Medical Research-Key Employees 25

French National Institute of Health and Medical Research-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Affiliate 26

Recent Developments 27

Government and Public Interest 27

Jun 01, 2018: Immunoscore: a test to improve the care and treatment of colon cancer 27

Product News 28

Aug 31, 2018: Implantable electronic device could stop epileptic seizures 28

Other Significant Developments 29

Aug 20, 2018: Bioengineered tooth replacement opens doors to new therapies 29

Appendix 30

Methodology 30

About GlobalData 30

Contact Us 30

Disclaimer 30


List Of Figure

List of Figures

French National Institute of Health and Medical Research, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

French National Institute of Health and Medical Research, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

French National Institute of Health and Medical Research, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

French National Institute of Health and Medical Research, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

French National Institute of Health and Medical Research, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

French National Institute of Health and Medical Research, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

French National Institute of Health and Medical Research, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

French National Institute of Health and Medical Research, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

French National Institute of Health and Medical Research, Medical Equipment, Key Facts 2

French National Institute of Health and Medical Research, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

French National Institute of Health and Medical Research, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

French National Institute of Health and Medical Research, Medical Equipment Deals By Type, 2012 to YTD 2018 6

French National Institute of Health and Medical Research, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

French National Institute of Health and Medical Research, Deals By Market, 2012 to YTD 2018 8

French National Institute of Health and Medical Research, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Eyevensys Secures Venture Funding 11

BioAxial Raises USD 2.6 Million In Series A Financing 12

Advanced Biological Labs Enters into Licensing Agreement with Inserm Transfert 13

Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 14

Tataa Biocenter Enters into Licensing Agreement with Inserm for ValidPrime Technology 15

IntegraGen Enters Into Licensing Agreement With Paris Descartes University For hsa-miR-31-3p 16

Qiagen Enters Into Licensing Agreement With Inserm Transfert For Colorectal Cancer Biomarker 18

Dassault Systemes Enters into Agreement with Inserm Transfert 19

Sebia Enters Into Co-Development Agreement With Institut National de la Sante And Inserm Transfert 20

Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 21

Inserm Transfert Enters into Licensing Agreement with HalioDx 22

PEP-Therapy Enters into Agreement with Inserm Transfert, Institut Curie and Pierre and Marie 23

French National Institute of Health and Medical Research, Key Competitors 24

French National Institute of Health and Medical Research, Key Employees 25

French National Institute of Health and Medical Research, Subsidiaries 26

French National Institute of Health and Medical Research, Affiliate 26

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

French National Institute of Health and Medical Research, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.